Filing Details

Accession Number:
0001214659-20-000278
Form Type:
4
Zero Holdings:
No
Publication Time:
2020-01-10 16:21:32
Reporting Period:
2019-12-23
Accepted Time:
2020-01-10 16:21:32
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1586105 Zyla Life Sciences ZCOR Pharmaceutical Preparations (2834) 463575334
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1676700 Riva Ridge Capital Management Lp 55 Fifth Street, Suite 1808
New York
New York NY 10003
No No No No
1777278 Riva Ridge Gp Llc 55 Fifth Street, Suite 1808
New York
New York NY 10003
No No No No
1777279 James Shim 55 Fifth Street, Suite 1808
New York
New York NY 10003
No No No No
1777281 H Stephen Golden 55 Fifth Street, Suite 1808
New York
New York NY 10003
No No No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock, Par Value $0.001 Per Share Disposition 2019-12-23 250,000 $2.50 988,661 No 4 S Indirect See Footnotes
Common Stock, Par Value $0.001 Per Share Disposition 2019-12-30 50,000 $2.50 938,661 No 4 S Indirect See Footnotes
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 S Indirect See Footnotes
No 4 S Indirect See Footnotes
Footnotes
  1. This Form 4 is being filed jointly by Riva Ridge Capital Management LP, a Delaware limited partnership ("RRCM"), Riva Ridge GP LLC, a Delaware limited liability company ("RRGP"), Stephen H. Golden ("Golden"), an individual, and James Shim ("Shim"), an individual (together, the "Reporting Persons"), with respect to certain securities of Zyla Life Sciences (f/k/a Egalet Corporation) (the "Issuer"). Neither the filing of this Form 4 nor any statements herein shall be deemed an admission that the Reporting Persons are members of a group, within the meaning of Section 13(d) of the Securities Exchange Act of 1934, as amended (the "Exchange Act"), with respect to any equity securities of the Issuer.
  2. RRCM is the investment adviser to certain investment funds and accounts, including Riva Ridge Master Fund, Ltd., a Cayman Islands exempted company (the "Master Fund"). The securities reported in this row are held directly by the Master Fund.
  3. Each of RRCM, as the investment adviser to the Master Fund, and RRGP, as the general partner of RRCM, may be deemed a beneficial owner of the Issuer's securities held by the Master Fund. Each of Golden and Shim, as a managing member of RRGP with the power to exercise investment discretion, may be deemed a beneficial owner of the Issuer's securities held by the Master Fund. Each of the Reporting Persons disclaims beneficial ownership of any securities of the Issuer reported or referenced herein, for purposes of Section 16 of the Exchange Act or otherwise, except to the extent of such Reporting Person's pecuniary interest, if any, therein.